# Open Label Comparative Trial of Dinoprostone Plus or Minus Oxytocin Versus Oxytocin Alone in Cervical Ripening for Labor Induction

> **NCT01190163** · PHASE4 · TERMINATED · sponsor: **Ferring Pharmaceuticals** · enrollment: 170 (actual)

## Conditions studied

- Vaginal Delivery
- Cesarean Section

## Interventions

- **DRUG:** Dinoprostone
- **DRUG:** Oxytocin

## Key facts

- **NCT ID:** NCT01190163
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-06
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 170 (ACTUAL)
- **Why stopped:** Study was early terminated due to problems enrolling adequate number of patients
- **Last updated:** 2012-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01190163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01190163, "Open Label Comparative Trial of Dinoprostone Plus or Minus Oxytocin Versus Oxytocin Alone in Cervical Ripening for Labor Induction". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01190163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*